Functional tricuspid regurgitation: A clustering analysis and prognostic validation of three echocardiographic phenotypes in an external cohort.

Atrial functional-TR Cluster analysis Prognosis Tricuspid regurgitation Ventricular functional-TR

Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 10 2022
Historique:
received: 24 04 2022
revised: 07 07 2022
accepted: 12 07 2022
pubmed: 20 7 2022
medline: 30 8 2022
entrez: 19 7 2022
Statut: ppublish

Résumé

Functional tricuspid regurgitation (FTR) is an independent risk factor for morbidity and mortality. New pathophysiological concepts but also new therapeutic options are justifying new knowledges for characterizing FTRs and their prognoses. To study echocardiographic criteria associated with prognosis in FTR-patients using a clustering method in two cohorts. Two hundred forty-one patients with at least severe (≥grade 3) TR were enrolled: 92 in the retrospective cohort (mean age 77.9 ± 13 years) and 149 in the prospective validation cohort. Hierarchical clustering analysis was conducted. Four parameters explained the clustering categorization according to a multinomial regression (right ventricular (RV) end-diastolic mid-cavity diameter, RV free-wall strain, right atrial (RA) volume index, RA strain; p = 0.0039). Three clusters were identified in the retrospective cohort: Cluster 1 had better right ventricular, left ventricular, and right atrial function than Cluster 2 (reduced RV and RA strain despite similar sizes). Cluster 3 included patients with severely dilated heart chambers associated to RV and RA dysfunctions. When applying the model in the validation (external) cohort, the rate of the primary endpoint (hospitalization for heart failure and/or death from any cause) was lowest in Cluster 1 (30.8% versus 48% and 58.8% in Clusters 2 and 3, respectively; p < 0.05). In FTR patients, different profiles of RV and RA remodeling are associated with different outcomes. Therefore, the diagnostic work-up in this clinical setting should include RV and RA characteristics. Under noninterventional management, the phenotype corresponding to preserved RV size and preserved RA and RV functions appears to have a better prognosis.

Sections du résumé

BACKGROUND
Functional tricuspid regurgitation (FTR) is an independent risk factor for morbidity and mortality. New pathophysiological concepts but also new therapeutic options are justifying new knowledges for characterizing FTRs and their prognoses.
AIM
To study echocardiographic criteria associated with prognosis in FTR-patients using a clustering method in two cohorts.
METHODS AND RESULTS
Two hundred forty-one patients with at least severe (≥grade 3) TR were enrolled: 92 in the retrospective cohort (mean age 77.9 ± 13 years) and 149 in the prospective validation cohort. Hierarchical clustering analysis was conducted. Four parameters explained the clustering categorization according to a multinomial regression (right ventricular (RV) end-diastolic mid-cavity diameter, RV free-wall strain, right atrial (RA) volume index, RA strain; p = 0.0039). Three clusters were identified in the retrospective cohort: Cluster 1 had better right ventricular, left ventricular, and right atrial function than Cluster 2 (reduced RV and RA strain despite similar sizes). Cluster 3 included patients with severely dilated heart chambers associated to RV and RA dysfunctions. When applying the model in the validation (external) cohort, the rate of the primary endpoint (hospitalization for heart failure and/or death from any cause) was lowest in Cluster 1 (30.8% versus 48% and 58.8% in Clusters 2 and 3, respectively; p < 0.05).
CONCLUSION
In FTR patients, different profiles of RV and RA remodeling are associated with different outcomes. Therefore, the diagnostic work-up in this clinical setting should include RV and RA characteristics. Under noninterventional management, the phenotype corresponding to preserved RV size and preserved RA and RV functions appears to have a better prognosis.

Identifiants

pubmed: 35853500
pii: S0167-5273(22)01088-9
doi: 10.1016/j.ijcard.2022.07.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-147

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Mathilde Vely (M)

University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, F-35000 Rennes, France.

Guillaume L'official (G)

University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, F-35000 Rennes, France.

Elena Galli (E)

University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, F-35000 Rennes, France.

Wojciech Kosmala (W)

Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.

Anne Guerin (A)

University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, F-35000 Rennes, France.

Elisabeth Chen (E)

University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, F-35000 Rennes, France.

Catherine Sportouch (C)

Clinique Le Millenaire, Montpellier, France.

Julien Dreyfus (J)

Centre Cardiologique du Nord, Saint Denis, France.

Emmanuel Oger (E)

EA Reperes, CHU Rennes, University Rennes, Rennes, France.

Erwan Donal (E)

University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, F-35000 Rennes, France. Electronic address: erwan.donal@chu-rennes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH